1. Home
  2. PBBK vs UBX Comparison

PBBK vs UBX Comparison

Compare PBBK & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBBK
  • UBX
  • Stock Information
  • Founded
  • PBBK 1919
  • UBX 2009
  • Country
  • PBBK United States
  • UBX United States
  • Employees
  • PBBK N/A
  • UBX N/A
  • Industry
  • PBBK Banks
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBBK Finance
  • UBX Health Care
  • Exchange
  • PBBK Nasdaq
  • UBX Nasdaq
  • Market Cap
  • PBBK 38.0M
  • UBX 20.4M
  • IPO Year
  • PBBK N/A
  • UBX 2018
  • Fundamental
  • Price
  • PBBK $16.45
  • UBX $0.96
  • Analyst Decision
  • PBBK
  • UBX Strong Buy
  • Analyst Count
  • PBBK 0
  • UBX 3
  • Target Price
  • PBBK N/A
  • UBX $5.33
  • AVG Volume (30 Days)
  • PBBK 4.3K
  • UBX 217.7K
  • Earning Date
  • PBBK 05-14-2025
  • UBX 05-13-2025
  • Dividend Yield
  • PBBK N/A
  • UBX N/A
  • EPS Growth
  • PBBK N/A
  • UBX N/A
  • EPS
  • PBBK 0.76
  • UBX N/A
  • Revenue
  • PBBK $12,444,000.00
  • UBX N/A
  • Revenue This Year
  • PBBK N/A
  • UBX N/A
  • Revenue Next Year
  • PBBK N/A
  • UBX N/A
  • P/E Ratio
  • PBBK $21.64
  • UBX N/A
  • Revenue Growth
  • PBBK 1.44
  • UBX N/A
  • 52 Week Low
  • PBBK $11.90
  • UBX $0.94
  • 52 Week High
  • PBBK $17.75
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • PBBK 56.22
  • UBX 26.07
  • Support Level
  • PBBK $16.41
  • UBX $1.16
  • Resistance Level
  • PBBK $16.60
  • UBX $1.22
  • Average True Range (ATR)
  • PBBK 0.30
  • UBX 0.13
  • MACD
  • PBBK -0.05
  • UBX -0.07
  • Stochastic Oscillator
  • PBBK 47.33
  • UBX 1.07

About PBBK PB Bankshares Inc.

PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: